Find Federal Grants
Centers for Disease Control and Prevention - ERA · RFA-OH-22-006
Extracellular RNA Sequencing Research Resource for the Accelerating Medicines Partnership Parkinsons Disease (AMPPD) (R24 - Clinical Trial Not Allowed)
National Institutes of Health · RFA-NS-23-014
Ethiopia USAID-Addis Ababa · 72060322RFI00009
Ethiopia USAID-Addis Ababa · 72066322RFI00008
Centers for Disease Control and Prevention - ERA · RFA-OH-22-005
Novel Assays to Address Translational Gaps in Treatment Development (UG3/UH3 Clinical Trial Optional)
National Institutes of Health · PAR-22-169
Regenerative Medicine Innovation Project (RMIP) Investigator-Initiated Clinical Trials (UG3/UH3 Clinical Trial Required)
National Institutes of Health · RFA-HL-23-017
Regenerative Medicine Innovation Projects (RMIP) Investigator- Initiated Studies (Collaborative U01 Clinical Trial Not Allowed)
National Institutes of Health · RFA-HL-23-019
Regenerative Medicine Innovation Projects (RMIP) Clinical Trial Planning Grant (R34 - Clinical Trials Not Allowed)
National Institutes of Health · RFA-HL-23-020
Complex Integrated Multi-Component Projects in Aging Research (U19 Clinical Trial Optional)
National Institutes of Health · PAR-22-213
New Epidemiological Cohort Study among Asian Americans, Native Hawaiians, and Pacific Islanders (AsA-NHPI): Coordinating Center (U24 - Clinical Trial Not Allowed)
National Institutes of Health · RFA-HL-23-016
New Epidemiological Cohort Study among Asian Americans, Native Hawaiians, and Pacific Islanders (AsA-NHPI): Clinical/Community Field Centers (UG3/UH3 - Clinical Trial Not Allowed)
National Institutes of Health · RFA-HL-23-015
Building in vivo Preclinical Assays of Circuit Engagement for Application in Therapeutic Development (R01 Clinical Trial Not Allowed)
National Institutes of Health · PAR-22-170
HEAL Initiative: Rapidly Assessing the Public Health Impact of Emerging Opioid Threats (UG1 - Clinical Trial Not Allowed)
National Institutes of Health · RFA-DA-23-045
CCRP Initiative: Countermeasures Against Chemical Threats (CounterACT) Therapeutics Discovery and Early-Stage Development (UG3/UH3 Clinical Trial Not Allowed)
National Institutes of Health · PAR-22-209
NIA Research and Entrepreneurial Development Immersion (REDI): Entrepreneurial Small Business Transition Award (R41/R42 Clinical Trial Optional)
National Institutes of Health · RFA-AG-23-030
NIA Research and Entrepreneurial Development Immersion (REDI): Entrepreneurial Small Business Transition Award (R43/R44 Clinical Trial Optional)
National Institutes of Health · RFA-AG-23-029
HEAL Initiative: Research to Foster an Opioid Use Disorder Treatment System Patients Can Count On (RM1 - Clinical Trial Optional)
National Institutes of Health · RFA-DA-23-046
National Institutes of Health · RFA-AG-23-017
Impact of the Microbiome-Gut-Brain Axis on Alzheimer's Disease and Alzheimer's Disease-Related Dementias (R01 Clinical Trial Not Allowed)
National Institutes of Health · PAR-22-211